In a significant leap forward for medical technology in Indonesia, SS Innovations International has announced the successful completion of the country’s first-ever robotic cardiac surgery. Conducted at the Harapan Kita National Cardiac Hospital in Jakarta, the procedure utilized the cutting-edge SSi Mantra surgical robotic system, highlighting the company's commitment to making advanced robotic surgeries both cost-effective and globally available.
The surgeries included a bilateral internal mammary artery coronary artery bypass graft (IMA CABG), an atrial septal defect (ASD) repair, and a beating heart totally endoscopic coronary artery bypass (TECAB). This groundbreaking operation was spearheaded by Dr. Sudhir Srivastava, the founder, chairman, and CEO of SS Innovations, along with a team from the company and dedicated staff at Harapan Kita, led by Dr. Dudy Hanafy.
SS Innovations, based in Gurugram, India, provides the proprietary SSi Mantra Surgical Robotic System and its complementary SSi Mudra instrumentation. The SSi Mantra 3, launched in July, offers an innovative modular setup, allowing surgeons to operate with three to five robotic arms. It features an open-faced ergonomic Surgeon Command Centre, accompanied by a 32-inch 3D 4K monitor and a 23-inch 2D Touch panel for patient information display.
With notable features such as real-time virtual imaging of the Patient Side Arm Carts and the ability to superimpose 3D diagnostic modeling, the SSi Mantra system supports revolutionary telesurgery capabilities. Furthermore, the Vision Cart grants the table-side team the same detailed 3D 4K view that the surgeon sees, enhancing both safety and operational efficiency. Its modular design affords flexibility in arm positioning, reducing the risk of collision during surgical operations.
The SSi Mantra boasts over 40 different types of robotic endo-surgical instruments suitable for various specialties, notably cardiac surgery. The company claims that surgeons can quickly adapt to this technology due to its ergonomic design and user-friendliness. Having been clinically validated over 80 different types of surgical procedures in India and used in more than 2,000 operations, the system is now setting its sights on global expansion, with regulatory approvals underway in the U.S. and the European Union, with an anticipated approval by 2025.
The introduction of robotic cardiac surgery at Harapan Kita marks what SS Innovations describes as the dawn of a new era in cardiac care for Indonesia, a country of over 284 million people and nearly 3,000 hospitals.
Dr. Iwan Dakota, the director and intervention cardiologist at NCVC Harapan Kita, shared his insights on adopting the technology. "We have been exploring the integration of robotic surgery in cardiovascular care at the Harapan Kita hospital and reviewed the globally available surgical robotic systems. We found that the SSi Mantra is the only system supporting the full spectrum of robotic cardiac surgery, including TECAB," noted Dr. Dakota. "Given its unique capabilities, we invited Dr. Srivastava’s team to demonstrate how the SSi Mantra performs compared to other systems. The potential for implementing robotic surgery in our country is highly promising."
Following the landmark TECAB procedure, SS Innovations and the Harapan Kita surgical team have continued their collaboration, performing seven to eight additional robotic-assisted procedures, encompassing LIMA, BIMA, TECAB, and ASD repairs.
Dr. Srivastava expressed pride in the partnership with Harapan Kita National Cardiac Hospital, stating, “We are proud to partner with Harapan Kita National Cardiac Hospital to bring the most technologically advanced and cost-effective solutions to cardiac surgery to Indonesia. Reaching this milestone with SSi Mantra is a testament to our vision of transforming surgical practices, enhancing access, and driving the global adoption of cost-effective robotic surgery.”
This milestone collaboration not only addresses the growing need for safe, timely, and affordable cardiac care but also offers patients less invasive surgical options that promise a better quality of life.
.png)
